Global PETAL Study Launches: Machine Learning Genomics Platform to Transform T-Cell Lymphoma Outcomes Prediction
247 Health News Editorial
·10 Apr 2026
·4 min read
·clinical-trialsThe global PETAL Consortium launches a groundbreaking study integrating machine learning with genomics to predict treatment outcomes in 1,200 patients with mature T-cell and NK-cell lymphomas. This observational study across four countries, including Australia, aims to identify genetic vulnerabilities that could transform personalised treatment approaches in these challenging malignancies.
Originally reported by ClinicalTrials.gov
References
- 1.PETAL Consortium. (2024). Integration of machine learning and genomics to predict outcomes for newly diagnosed, relapsed and refractory mature T-cell and NK/T-cell lymphomas: A global study of the PETAL consortium. ClinicalTrials.gov. NCT06067347. https://clinicaltrials.gov/study/NCT06067347
- 2.Swerdlow, S. H., Campo, E., Pileri, S. A., Harris, N. L., Stein, H., Siebert, R., Advani, R., Ghielmini, M., Salles, G. A., Zelenetz, A. D., & Jaffe, E. S. (2016). The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood, 127(20), 2375-2390. https://doi.org/10.1182/blood-2016-01-643569
- 3.Bellei, M., Foss, F. M., Shustov, A. R., Horwitz, S. M., Marcheselli, L., Kim, W. S., Cabrera, M. E., Dlouhy, I., Nagler, A., Advani, R. H., Pesce, E. A., Spina, M., Gaidano, G., Borchmann, P., Pileri, S., Paulli, M., Onida, F., Zinzani, P. L., Savage, K. J., ... Federico, M. (2018). The outcome of peripheral T-cell lymphoma patients failing first-line therapy: A report from the prospective, International T-Cell Project. Haematologica, 103(7), 1191-1197. https://doi.org/10.3324/haematol.2017.172379
- 4.Gallamini, A., Stelitano, C., Calvi, R., Bellei, M., Mattei, D., Vitolo, U., Morabito, F., Martelli, M., Brusamolino, E., Iannitto, E., Zaja, F., Cortelazzo, S., Rigacci, L., Devizzi, L., Todeschini, G., Santini, G., Brugiatelli, M., & Federico, M. (2004). Peripheral T-cell lymphoma unspecified (PTCL-U): A new prognostic model from a retrospective multicentric clinical study. Blood, 103(7), 2474-2479. https://doi.org/10.1182/blood-2004-02-0566
- 5.Moskowitz, A. J., Lunning, M. A., & Horwitz, S. M. (2014). How I treat the peripheral T-cell lymphomas. Blood, 123(17), 2636-2644. https://doi.org/10.1182/blood-2013-12-516245
2
247 Health News Editorial
247 Health News is a medical intelligence platform delivering evidence-based research appraisals, clinical trial monitoring, and health technology news for healthcare professionals.
Related Articles
clinical-trials
Digital Health Platform vs Case Manager Support in Hypertension Management: Taiwan's 1,726-Participant Trial Signals a Shift in Blood Pressure Care Delivery
3 Aug 2026
clinical-trials
Phase II Trial: AI-Powered Wysa Chatbot vs Unmet Need — Digital Eating Disorder Prevention in At-Risk Adolescents
3 Aug 2026
clinical-trials
Pilot Trial Targets the Inpatient-to-Outpatient Gap: Digital Smoking Cessation Intervention for Persons With Serious Mental Illness — Key Findings for Clinicians
3 Aug 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service